Bridging Pharmaceutical Rigor with AI Agility

Transforming
complexity into profit
and uncertainty into strategy.

I combine the rigor of a Pharma Executive, the vision of a Strategic Investor, the drive of an Intra&Entrepreneur and the technical capability to build Custom AI Agents that help solve complex problems.

Real Problems. Agentic Solutions.

In RB Pharma, I transformed an operation on the brink of insolvency into a profitable and sustainable company in 8 months.

This involved financial restructuring, rebuilding the team (from 2 to 8 members), and restoring market confidence.

"Turnaround & Recovery, Crisis Management, and Rapid Execution."

The RB Pharma Turnaround (8 Months)

Revenue Generated
€1M+
Verified
Team Reconstruction
2 8
High-Performance Elements
(Rebuilt from collapse; prev. 15 FTEs)
Tech Enabler
> Custom Agents for Treasury, Ops & Regulatory Compliance
> MVP "Wixmed" kept active and operational for internal team and beta test external clients
The Strategic Vision

The "Agentic Velocity" Model

An Agentic Workflow model helps to compress supply chain latency from days to hours.

Target Response Velocity

Standard Industry State: Manual processes bottlenecking the supply chain.

Target Velocity
168h

The Hybrid Profile

Competency Matrix

Academic & Strategic Foundation

Executive MBA
AESE Business School
Strategy
MSc Econ & Innovation
ISEG - Lisbon School of Econ
Policy
PharmD
ISCSEM
Science
2025 - Present

Building The Agentic Architecture for Pharma and SMEs

PTC.AI

Pioneering 'Agentic Business Strategy' for the Pharma sector. I don't just advise on AI; I build the autonomous systems that rescue distressed assets. Bridging the gap between C-Level strategy and code-level execution

2025

The Turnaround Executive

RB Pharma

Took a paralyzed company and supply chain. Rebuilt core team and deployed custom AI Agents to support treasury, compliance, and logistics. Result: Stabilized a critical situation and generated >€1M in revenue in under 8 months.

2017 - 2025

The Corporate Agilist

Alliance Healthcare/Cencora

Navigated the complexities of a failure-intolerant €750M multinational. Built new BU and set market references for GPOs. Championed digital transformation and agile methodologies within a rigid corporate structure, leaded multi-year strategy plan, laying the groundwork for innovation and growth.

2013 - Present

The Skin-in-the-Game Investor

Atelier 560, Pharmacy Owner

I understand business because I own businesses. From retail concepts to real estate, I build resilient assets that withstand market volatility. My advice is backed by my own capital.

2009 - 2013

The Intrapreneurial Shareholder

Grupo Holon

As a shareholder, I didn't just manage; I built. Founded new business units and drove business development strategies, blending the roles of investor and operator.

1998 - 2009

The Scientific Foundation

PharmD

Started in the lab as a Junior Research Scientist before moving to community pharmacy leadership. My approach to business is rooted in the rigorous scientific method.

Beyond the Resume

My interests span from agentic architectures to retail investments. The Lab is where I test, fail, and iterate on new ideas.